Jefferies Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.2M Sell
23,030
-37,306
-62% -$37.8M 0.15% 112
2025
Q4
$64.8M Sell
60,336
-239,293
-80% -$229M 0.33% 49
2025
Q3
$229M Buy
299,629
+291,501
+3,586% +$217M 1.08% 11
2025
Q2
$6.34M Buy
8,128
+2,146
+36% +$1.67M 0.05% 243
2025
Q1
$4.94M Sell
5,982
-2,861
-32% -$2.38M 0.04% 294
2024
Q4
$6.83M Buy
8,843
+5,342
+153% +$4.42M 0.04% 289
2024
Q3
$3.1M Sell
3,501
-9,226
-72% -$8.29M 0.02% 445
2024
Q2
$11.5M Sell
12,727
-887
-7% -$710K 0.12% 133
2024
Q1
$10.6M Sell
13,614
-12,121
-47% -$8.63M 0.1% 162
2023
Q4
$15M Sell
25,735
-9,135
-26% -$5.33M 0.1% 146
2023
Q3
$18.7M Buy
34,870
+8,286
+31% +$4.27M 0.17% 87
2023
Q2
$12.5M Sell
26,584
-34,486
-56% -$14.5M 0.11% 167
2023
Q1
$21M Sell
61,070
-16,597
-21% -$5.6M 0.17% 104
2022
Q4
$28.4M Buy
+77,667
New +$27.5M 0.2% 83
2016
Q2
Sell
-3,600
Closed -$259K 60
2016
Q1
$259K Buy
+3,600
New +$272K 0.04% 34

Other funds holding LLY

Jefferies Financial Group's LLY Position: Q1 2026 in Review

Jefferies Financial Group reduced its Eli Lilly (LLY) stake by 62% in Q1 2026, selling an estimated $37.8M and leaving 23,030 shares worth $21.2M. The position accounts for 0.15% of the portfolio, ranked #112.

Jefferies Financial Group first reported a position in LLY in Q1 2016 and has held it in 15 quarters since. The position peaked at $229M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Jefferies Financial Group held 23,030 shares of Eli Lilly worth $21.2M as of Q1 2026.
  • Jefferies Financial Group sold 37,306 Eli Lilly shares in Q1 2026, an estimated $37.8M.
  • Eli Lilly made up 0.15% of Jefferies Financial Group's portfolio in Q1 2026, its #112 holding.
  • Jefferies Financial Group first reported a position in Eli Lilly in Q1 2016 and has held it in 15 quarters since.
  • Jefferies Financial Group's Eli Lilly position peaked at $229M in Q3 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.